...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: More options exercised, this time by Ewelina Kulikowski

Toinv, Not sure about the option expiries as I haven’t looked but the fact that there was no concurrent sale of shares by Kulikowski, Cann or Lebioda would suggest the shares are being held by all three individuals. Someone else suggested and I agree that perhaps if they view the company as having a good chance of BOM success then they might be exercising the options while the share price is still relatively cheap in order to put the shares in tax advantaged accounts before the sp “takes off”

New Message
Please login to post a reply